Beijing Hotgen Biotech Co Ltd Free Cash Flow Generation Index

Latest as of September 2025: -3.82x

Beijing Hotgen Biotech Co Ltd free cash flow generation index. Beijing Hotgen Biotech Co Ltd (688068) has a Free Cash Flow Generation Index of -3.82x as of September 2025. Free cash flow of CN¥-11.68 Million represents -4% of operating cash flow (CN¥3.05 Million).

FCF Generation Index

-3.82x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥-11.68 Million
CNY

Operating Cash Flow

CN¥3.05 Million
CNY

Capital Expenditures

CN¥14.73 Million
CNY

Free Cash Flow Generation Index of Beijing Hotgen Biotech Co Ltd (2016–2022)

Free cash flow generation index of Beijing Hotgen Biotech Co Ltd from 2016 to 2022. Historical FCF Generation Index trend for Beijing Hotgen Biotech Co Ltd across 7 annual periods. See Beijing Hotgen Biotech Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Beijing Hotgen Biotech Co Ltd Free Cash Flow Generation Index by Year (2016–2022)

Beijing Hotgen Biotech Co Ltd free cash flow generation index by year from 2016 to 2022. Year-by-year Free Cash Flow Generation Index for Beijing Hotgen Biotech Co Ltd. For the full cash flow conversion analysis, see Beijing Hotgen Biotech Co Ltd (688068) cash conversion ratio.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2022 0.42x CN¥413.54 Million CN¥978.75 Million CN¥565.21 Million ▼ -50.2%
2021 0.85x CN¥2.25 Billion CN¥2.64 Billion CN¥398.86 Million ▲ +1928.4%
2020 -0.05x CN¥-7.65 Million CN¥164.62 Million CN¥172.27 Million ▲ +98.7%
2019 -3.57x CN¥-69.11 Million CN¥19.37 Million CN¥88.48 Million ▼ -1606.4%
2018 0.24x CN¥13.03 Million CN¥55.04 Million CN¥42.00 Million ▲ +111.8%
2017 -2.01x CN¥-46.10 Million CN¥22.95 Million CN¥69.05 Million ▼ -475.5%
2016 0.53x CN¥24.36 Million CN¥45.54 Million CN¥21.18 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).